Company news

AbCellera Biologics Inc. news in 2023

AbCellera Biologics Inc.'s news releases, calls and decks from 2023, newest first.

View company

AbCellera to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024

December 19, 2023

AbCellera to Present at the Piper Sandler 35th Annual Healthcare Conference on November 30, 2023

November 15, 2023

AbCellera Presents New Data on Two T-Cell Engager Programs at SITC 2023

November 2, 2023

AbCellera Reports Q3 2023 Business Results

November 1, 2023

Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology

October 31, 2023

AbCellera to Present at the Jefferies London Healthcare Conference on November 14, 2023

October 30, 2023

AbCellera to Report Third Quarter 2023 Financial Results on November 2, 2023

October 10, 2023

AbCellera Announces Two T-Cell Engager Presentations at SITC 2023

September 26, 2023

AbCellera Expands Multi-Target Antibody Discovery Collaboration with Regeneron

September 19, 2023

AbCellera Announces Collaboration with Incyte to Accelerate the Discovery and Development of Therapeutic Antibodies in Oncology

September 12, 2023

AbCellera Reports Q2 2023 Business Results

August 2, 2023

AbCellera Announces that the U.S. Patent Trial and Appeal Board Has Denied Berkeley Lights’ Request for Rehearing

July 23, 2023

AbCellera to Report Second Quarter 2023 Financial Results on August 3, 2023

July 5, 2023

AbCellera to Present at the Goldman Sachs 44th Annual Global Healthcare Conference on June 13, 2023

May 28, 2023

AbCellera Partners with the Governments of Canada and British Columbia to Advance Drug Development Capabilities and Infrastructure that Will Accelerate Innovative Medicines to Patients

May 23, 2023

AbCellera Reports Q1 2023 Business Results

May 3, 2023

AbCellera Presents New Data on T-Cell Engager Platform at AACR 2023

April 16, 2023

AbCellera to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference on April 25, 2023

April 10, 2023

AbCellera to Report First Quarter 2023 Financial Results on May 4, 2023

April 5, 2023

AbCellera and RQ Bio Partner to Accelerate the Advancement of New Therapies for Infectious Disease

March 21, 2023

AbCellera Announces Two Presentations on T-Cell Engager Discovery at AACR 2023

March 13, 2023

AbCellera to Present at the Cowen 43rd Annual Health Care Conference on March 6, 2023

February 22, 2023

AbCellera Reports Full Year 2022 Business Results

February 20, 2023

AbCellera to Present at the SVB Securities Global Biopharma Conference on February 15, 2023

January 31, 2023

AbCellera to Report Full Year 2022 Financial Results on February 21, 2023

January 23, 2023

AbCellera Announces that the U.S. Patent Trial and Appeal Board Upholds Microfluidic Cell Culture Patent

January 18, 2023

AbCellera to Present at the 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023

January 3, 2023

Calls in 2023

Decks in 2023